Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-04-22
2008-04-22
Shiao, Rei-tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S201000
Reexamination Certificate
active
10503391
ABSTRACT:
There are provided a solid preparation containing a single crystal of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid, an excipient and a disintegrating agent, and a method for producing the same.
REFERENCES:
patent: 5614520 (1997-03-01), Kondo et al.
patent: 6225474 (2001-05-01), Matsumoto et al.
patent: 0513379 (1992-11-01), None
patent: 0779074 (1997-06-01), None
patent: 1 020 454 (1999-12-01), None
patent: 1020454 (2000-07-01), None
patent: WO 92/09279 (1992-06-01), None
patent: WO 99/65885 (1999-12-01), None
M. Kitamura, et al., Effects of solvent composition and temperature on polymorphism and crystallization behavior of thiazole-derivative, Journal of Crystal Growth, Mar. 2002, vol. 236, No. 4, pp. 676 to 686.
Dohi Masahiko
Iwai Michio
Mochizuki Hiroko
Mochizuki Seiji
Nakamura Kazuhiro
Shiao Rei-tsang
Sughrue & Mion, PLLC
Teijin Limited
LandOfFree
Solid preparation containing single crystal form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid preparation containing single crystal form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid preparation containing single crystal form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3956303